Hodgkin lymphoma: the follow-up of long-term survivors.
Hodgkin lymphoma (HL) is a disease that typically strikes children and young adults, with more than 80% of those affected being cured. Consequently, HL survivors can live for decades with the persistent and late-emerging effects of the disease and its treatment. The focus of this article is the long-term medical management of HL survivors, specifically those who are 5 years or more off therapy without evidence of relapse, when the focus of follow-up care shifts from detecting relapse to minimizing the morbidity associated with the late effects of treatment.
Hodgson
David C
DC
Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto M5G 2M9, Canada. david.hodgson@rmp.uhn.on.ca
D000359:Aftercare / Q000379:methods; D002318:Cardiovascular Diseases / Q000175:diagnosis; D006689:Hodgkin Disease / Q000534:rehabilitation* / Q000628:therapy; D006801:Humans; D016609:Neoplasms, Second Primary / Q000175:diagnosis; D017410:Practice Guidelines as Topic; D017741:Survivors